Cancer Cell Membrane-Coated NPs as a Biomimetic Strategy for Precision Tumor Therapy
Pharmaceutics · 11.10.2025 · 17 (10) · 1322
DOI: 10.3390/pharmaceutics17101322 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 11.10.2025. Verfasst von Junyi Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68106, USA. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, FPBCC Cancer Center Support Grant, National Institute of Health grants.
Abstract (Originalsprache)
Cancer treatment remains challenging due to the complexity of the tumor microenvironment, which promotes tumor heterogeneity and contributes to the development of multidrug resistance, ultimately hindering drug delivery and reducing therapeutic efficacy. In recent years, biomimetic nanocarriers have emerged as promising tools to address these challenges. Among them, cancer cell membrane (CCM)-coated nanoparticles (CCM-NPs) have attracted increasing attention due to their unique advantages, including homologous targeting, prolonged circulation mediated by self-recognition, and enhanced tumor penetration. Moreover, CCM-NPs can serve as versatile platforms for tumor vaccines by leveraging their inherent tumor-associated antigens and immunomodulatory potential. By leveraging CCMs to functionalize NPs, researchers have developed innovative approaches to improve drug delivery, enhance tumor immunotherapy, and optimize cancer vaccine efficacy. Despite these advancements, a comprehensive review summarizing the latest progress in CCM-based biomimetic nanocarriers for tumor treatment is lacking. This review integrates recent advances in CCM-NPs for targeted drug delivery and cancer vaccination, and discusses their fabrication, characterization, mechanisms and applications across multiple cancer types, which provides timely insights to guide their future development in precision tumor therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68106, USA.
- Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68106, USA.
ORCID-Profile: Jingjing Sun
Förderung
- NCI NIH HHS
- FPBCC Cancer Center Support Grant
- National Institute of Health grants
- National Institute of Health
- FPBCC Cancer Center Support
Zitieren
APA
Lin, J., Li, W., Aboushanab, A. R., & Sun, J. (2025). Cancer Cell Membrane-Coated NPs as a Biomimetic Strategy for Precision Tumor Therapy. Pharmaceutics, 17(10), 1322. https://doi.org/10.3390/pharmaceutics17101322
Vancouver
Lin J, Li W, Aboushanab AR, Sun J. Cancer Cell Membrane-Coated NPs as a Biomimetic Strategy for Precision Tumor Therapy. Pharmaceutics. 2025;17(10):1322. doi:10.3390/pharmaceutics17101322
BibTeX
@article{Lin2025,
author = {Lin, Junyi and Li, Wei and Aboushanab, Alaa R and Sun, Jingjing},
title = {Cancer Cell Membrane-Coated NPs as a Biomimetic Strategy for Precision Tumor Therapy},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {10},
pages = {1322},
doi = {10.3390/pharmaceutics17101322}
}
EUVIMED